Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Reference
Zouboulis CC (2000) Human skin: an independent peripheral endocrine organ. Horm Res 54:230–242
Ebling FJG (1990) The hormonal control of hair growth. In: Orfanos CE, Happle R, (eds) Hair and hair growth. Springer, Berlin Heidelberg New York, pp 267–99
Fritsch M, Orfanos CE, Zouboulis CC (2001) Sebocytes are the key regulators of androgen homeostasis in human skin. J Invest Dermatol 116:793–800
Suzuki I, Cone CD, Im S, Nordlund J, Abdel-Malek ZA (1996) Binding of melanocortin hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 137:1627–1633
Deplewski D, Rosenfield RL (2000) Role of hormones in pilosebaceous unit development. Endocr Rev 21:363–392
Stenn KS, Paus R (2001) Control of hair follicle cycling. Physiol Rev 81:449–494
Labrie F, Luu-The V, Labrie C, Pelletier G, El-Alfy M (2000) Intracrinology and the skin. Horm Res 54:218–229
Orfanos CE, Adler YD, Zouboulis CC (2000) The SAHA syndrome. Horm Res 54:251–258
Phillips TJ, Demircay Z, Sahu M (2001) Hormonal effects on skin aging. Clin Geriatr Med 17:661–672
Thiboutot DM (1995) Dermatological manifestations of endocrine disorders. J Clin Endocrinol Metab 80:3082–3087
Greenspan FS, Gardner DG (2001) Basic and clinical endocrinology, 6th edn. McGraw Hill, New York
Brincat MP (2000) Hormone replacement therapy and the skin. Maturitas 35:107–117
Morley JE (2001) Androgens and aging. Maturitas 38:61–73
Callens A, Vaillant L, Lecomte P, Berson M, Gall Y, Lorette G (1996) Does hormonal skin aging exist? A study of the influence of different hormone therapy regimens on the skin of postmenopausal women using non-invasive measurement techniques. Dermatology 193:289–294
Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE (1990) Effects of human growth hormone in men over 60 years old. N Engl J Med 323:1–6
Raine-Fenning NJ, Brincat MP, Muscat-Baron Y (2003) Skin aging and menopause: implications for treatment. Am J Clin Dermatol 4:371–378
Sator PG, Schmidt JB, Rabe T, Zouboulis CC (2004) Skin aging and sex hormones in women — clinical perspectives for intervention by hormone replacement therapy. Exp Dermatol 13[Suppl 4]:36–40
Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y (2000) Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor γ2. Endocrinology 141:649–656
Tavakkol A, Varani J, Elder JT, Zouboulis CC (1999) Maintenance of human skin in organ culture: role for insulin-like growth factor-1 receptor and epidermal growth factor receptor. Arch Dermatol Res 291:643–651
Ma H, Sprecher HW, Kolattukudy PE (1998) Estrogen-induced production of a peroxisome proliferator-activated receptor (PPAR) ligand in a PPARγ-expressing tissue. J Biol Chem 273:30131–30138
Rosenfield RL, Kentsis A, Deplewski D, Ciletti N (1999) Rat preputial sebocyte differentiation involves peroxisome proliferator-activated receptors. J Invest Dermatol 112:226–232
Miller KK (2001) Androgen deficiency in women. J Clin Endocrinol Metab 86:2395–2401
Makrantonaki E, Oeff MK, Fimmel S, Zouboulis CC (2003) Molecular mechanisms of hormone-induced skin aging. Exp Dermatol 12:333
Chen W, Yang C-C, Sheu H-M, Seltmann H, Zouboulis CC (2003) Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol 121:441–447
Oettel M (2002) Is there a role for estrogens in the maintenance of men’s health? Aging Male 5:248–257
Katz MS (2000) Geriatric grand rounds: Eve’s rib, or a revisionist view of osteoporosis in men. J Gerontol A Biol Sci Med Sci 55:M560–569
Brossner C, Petritsch K, Fink K, Auprich M, Madersbacher S, Adlercreutz H, Rehak P, Petritsch P (2004) Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases. Urology 64:707–711
Ponholzer A, Plas E, Schatzl G, Jungwirth A, Madersbacher S (2002) Austrian Society of Urology. Association of DHEA-S and estradiol serum levels to symptoms of aging men. Aging Male 5:233–238
Juul A, Skakkebaek NE (2002) Androgens and the ageing male. Hum Reprod Update 8:423–433
Von Eckardstein S, Nieschlag E (2000) Therapie mit Sexualhormonen beim alternden Mann. Dt Ärztebl 97:A3175–3182
Kao JS, Garg A, Mao-Qiang M, Crumrine D, Ghadially R, Feingold KR, Elias PM (2001) Testosterone perturbs epidermal permeability barrier homeostasis. J Invest Dermatol 116:443–451
Gilliver SC, Wu F, Ashcroft GS (2003) Regulatory roles of androgens in cutaneous wound healing. Thromb Haemost 90:978–985
Gambera A, Scagliola P, Falsetti L, Sartori E, Bianchi U (2004) Androgens, insulin-like growth factor-I (IGF-I), and carrier proteins (SHBG, IGFBP-3) in postmenopause. Menopause 11:159–166
Ghizzani A, Razzi S, Fava A, Sartini A, Picucci K, Petraglia F (2003) Management of sexual dysfunctions in women. J Endocrinol Invest 26[Suppl 3]:137–138
Buvat J (2003) Androgen therapy with dehydroepiandrosterone. World J Urol 21:346–355
Hennessey JV, Chromiak JA, DellaVentura S, Reinert SE, Puhl J, Kiel DP, Rosen CJ, Vandenburgh H, MacLean DB (2001) Growth hormone administration and exercise effects on muscle fiber type and diameter in moderately frail older people. J Am Geriatr Soc 49:852–858
Kann PH (2003) Growth hormone in anti-aging medicine: a critical review. Aging Male 6:257–263
Harman SM, Blackman MR (2004) Use of growth hormone for prevention or treatment of effects of aging. J Gerontol A Biol Sci Med Sci 59:652–658
Savine R, Sonksen P (2000) Growth hormone — hormone replacement for the somatopause? Horm Res 53[Suppl 3]:37–41
Mauras N, Rini A, Welch S, Sager B, Murphy SP (2003) Synergistic effects of testosterone and growth hormone on protein metabolism and body composition in prepubertal boys. Metabolism 52:964–969
Prakasam G, Yeh JK, Chen MM, Castro-Magana M, Liang CT, Aloia JF (1999) Effects of growth hormone and testosterone on cortical bone formation and bone density in aged orchiectomized rats. Bone 24:491–497
Lissett CA, Shalet SM (2003) The insulin-like growth factor-I generation test: peripheral responsiveness to growth hormone is not decreased with ageing. Clin Endocrinol (Oxf) 58:238–245
Weber MM (2002) Effects of growth hormone on skeletal muscle. Horm Res 58[Suppl 3]:43–48
Akamatsu H, Zouboulis CC, Orfanos CE (1992) Control of human sebocyte proliferation in vitro by testosterone and 5-alpha-dihydrotestosterone is dependent on the localization of the sebaceous glands. J Invest Dermatol 99:509–511
Deplewski D, Rosenfield RL (1999) Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 140:4089–4094
Zouboulis CC, Makrantonaki E (2003) Molekulare Mechanismen der hormonellen Hautalterung. J Dtsch Dermatol Gesellschaft 1[Suppl 1]:S94
Ruiz-Torres A, Soares de Melo Kirzner M (2002) Ageing and longevity are related to growth hormone/ insulin-like growth factor-1 secretion. Gerontology 48:401–407
Lee KS, Oh KY, Kim BC (2000) Effects of dehydroepiandrosterone on collagen and collagenase gene expression by skin fibroblasts in culture. J Dermatol Sci 23:103–110
Baulieu E-E, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L, Hervy M-P, Latour F, Leaud M-C, Mokrane A, Pitti-Ferrandi H, Trivalle C, de Lacharrière O, Nouveau S, Rakoto-Arison B, Souberbielle J-C, Raison J, Le Bouc Y, Raynaud A, Girerd X, Forette F (2000) Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobio-medical issue. Proc Natl Acad Sci U S A 97:4279–4284
Percheron G, Hogrel JY, Denot-Ledunois S, Fayet G, Forette F, Baulieu EE, Fardeau M, Marini JF (2003) Double-blind placebo-controlled trial. Effect of 1-year oral administration of dehydroepiandrosterone to 60-to 80-year-old individuals on muscle function and cross-sectional area: a double-blind placebo-controlled trial. Arch Intern Med 163:720–727
Genazzani AR, Inglese S, Lombardi I, Pieri M, Bernardi F, Genazzani AD, Rovati L, Luisi M (2004) Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency. Aging Male 7:133–143
Allolio B, Arlt W (2002) DHEA treatment: myth or reality? Trends Endocrinol Metab 13:288–294
Huber J, Gruber C (2001) Immunological and dermatological impact of progesterone. Gynecol Endocrinol 15[Suppl 6]:18–21
Wieser F, Hosmann J, Tschugguel W, Czerwenka K, Sedivy R, Huber JC (2001) Progesterone increases the number of Langerhans cells in human vaginal epithelium. Fertil Steril 75:1234–1235
Mingjia L, Short R (2002) How oestrogen or progesterone might change a woman’s susceptibility to HIV-1 infection. Aust N Z J Obstet Gynaecol 42:472–475
Fischer TW, Elsner P (2001) The antioxidative potential of melatonin in the skin. Curr Probl Dermatol 29:165–174
Abdel-Wahhab MA, Abdel-Galil MM, El-Lithey M (2005) Melatonin counteracts oxidative stress in rats fed an ochratoxin A contaminated diet. J Pineal Res 38:130–135
Fischer TW, Greif C, Fluhr JW, Wigger-Alberti W, Elsner P (2004) Percutaneous penetration of topically applied melatonin in a cream and an alcoholic solution. Skin Pharmacol Physiol 17:190–194
Fischer T, Bangha E, Elsner P, Kistler GS (1999) Suppression of UV-induced erythema by topical treatment with melatonin. Influence of the application time point. Biol Signals Recept 8:132–135
Wespes E, Schulman CC (2002) Male andropause: myth, reality, and treatment. Int J Impot Res 14[Suppl 1]:S93–98
Traustadottir T, Bosch PR, Matt KS (2005) The HPA axis response to stress in women: effects of aging and fitness. Psychoneuroendocrinology 30:392–402
Kaplan MM, Pan CY, Gordon PR, Lee JK, Gilchrest BA (1988) Human epidermal keratinocytes in culture convert thyroxine to 3,5,3′-triiodothyronine by type II iodothyronine deiodination: a novel endocrine function of the skin. J Clin Endocrinol Metab 66:815–822
Morrow LB (1978) How thyroid disease presents in the elderly. Geriatrics 33:42–45
Mirza FS, Prestwood KM (2004) Bone health and aging: implications for menopause. Endocrinol Metab Clin North Am 33:741–759
Vieth R, Ladak Y, Walfish PG (2003) Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab 88:185–191
Dawson-Hughes B (2004) Racial/ethnic considerations in making recommendations for vitamin D for adult and elderly men and women. Am J Clin Nutr 80[Suppl 6]:1763S–1766S
Zouboulis CC (2004) The human skin as a hormone target and an endocrine gland. Hormones 3:9–26
Cao T, Tsai SY, O’Malley BW, Wang XJ, Roop DR (2002) The epidermis as a bioreactor: topically regulated cutaneous delivery into the circulation. Hum Gene Ther 13:1075–1080
Lemmey AB, Glassford J, Flick-Smith HC, Holly JM, Pell JM (1997) Differential regulation of tissue insulin-like growth factor-binding protein (IGFBP)-3, IGF-I and IGF type 1 receptor mRNA levels, and serum IGF-I and IGFBP concentrations by growth hormone and IGF-I. J Endocrinol 154:319–328
Zouboulis CC, Degitz K (2004) Androgen action on human skin — from basic research to clinical significance. Exp Dermatol 13[Suppl 4]:5–10
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zouboulis, C.C., Makrantonaki, E. (2006). The Role of Hormones in Intrinsic Aging. In: Gilchrest, B.A., Krutmann, J. (eds) Skin Aging. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-32953-6_6
Download citation
DOI: https://doi.org/10.1007/3-540-32953-6_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-24443-1
Online ISBN: 978-3-540-32953-4
eBook Packages: MedicineMedicine (R0)